The evaluation of the efficacy and safety about apatinib combined with immune checkpoint inhibitors in advanced gastric cancer: a real-world study

The evaluation of the efficacy and safety about apatinib combined with immune checkpoint inhibitors in advanced gastric cancer: a real-world study

BackgroundApatinib and immune checkpoint inhibitors (ICIs) have shown promise as third-line treatments for advanced gastric cancer (AGC). This study compared the efficacy and safety of apatinib combined with ICIs versus apatinib monotherapy in AGC patients after second-line treatment failure.Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng-Fei Zhu, Liu Yang, Zhe-Ling Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
gastric cancer
immunotherapy
apatinib
survival time
prognosis
antiangiogenesis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1578011/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items